文献速递流行病学与生物统计组学、生物样本库与精准医学

幽门螺杆菌、同源重组基因与胃癌

Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer.
PubMed 文献 · N Engl J Med · 2023-01-01

基于BioBank Japan的10,426例胃癌患者与38,153例对照,评估27个癌症易感基因胚系致病变异与胃癌风险的关联;并在HERPACC的1,433例胃癌患者与5,997例对照中分析致病变异与幽门螺杆菌感染的联合效应及累积风险。

要点

  • APC、ATM、BRCA1、BRCA2、CDH1、MLH1、MSH2、MSH6和PALB2共9个基因的胚系致病变异与胃癌风险相关。
  • HERPACC样本中幽门螺杆菌感染与同源重组基因致病变异对胃癌风险存在交互作用,相对超额风险为16.01(95%CI 2.22至29.81;P=0.02)。
  • 85岁时,幽门螺杆菌感染且携带致病变异者的胃癌累积风险为45.5%(95%CI 20.7至62.6),高于幽门螺杆菌感染的非携带者的14.4%(95%CI 12.2至16.6)。

核心结论

  • 幽门螺杆菌感染改变了同源重组基因胚系致病变异相关的胃癌风险。

研究设计与样本

  • 基于BioBank Japan的病例对照研究,纳入10,426例胃癌患者和38,153例对照,评估27个癌症易感基因胚系致病变异与胃癌风险的关联。
  • 在HERPACC的1,433例胃癌患者和5,997例对照中评估致病变异与幽门螺杆菌感染状态对胃癌风险的联合效应,并计算累积风险。

主要发现

  • APC、ATM、BRCA1、BRCA2、CDH1、MLH1、MSH2、MSH6和PALB2共9个基因的胚系致病变异与胃癌风险相关。
  • HERPACC样本中,幽门螺杆菌感染与同源重组基因致病变异对胃癌风险的交互作用相对超额风险为16.01(95%CI 2.22至29.81;P=0.02)。
  • 85岁时,幽门螺杆菌感染且携带致病变异者的胃癌累积风险为45.5%(95%CI 20.7至62.6),幽门螺杆菌感染的非携带者为14.4%(95%CI 12.2至16.6)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Helicobacter pylori infection is a well-known risk factor for gastric cancer. However, the contribution of germline pathogenic variants in cancer-predisposing genes and their effect, when combined with H. pylori infection, on the risk of gastric cancer has not been widely evaluated. METHODS: We evaluated the association between germline pathogenic variants in 27 cancer-predisposing genes and the risk of gastric cancer in a sample of 10,426 patients with gastric cancer and 38,153 controls from BioBank Japan. We also assessed the combined effect of pathogenic variants and H. pylori infection status on the risk of gastric cancer and calculated the cumulative risk in 1433 patients with gastric cancer and 5997 controls from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). RESULTS: Germline pathogenic variants in nine genes (APC, ATM, BRCA1, BRCA2, CDH1, MLH1, MSH2, MSH6, and PALB2) were associated with the risk of gastric cancer. We found an interaction between H. pylori infection and pathogenic variants in homologous-recombination genes with respect to the risk of gastric cancer in the sample from HERPACC (relative excess risk due to the interaction, 16.01; 95% confidence interval [CI], 2.22 to 29.81; P = 0.02). At 85 years of age, persons with H. pylori infection and a pathogenic variant had a higher cumulative risk of gastric cancer than noncarriers infected with H. pylori (45.5% [95% CI, 20.7 to 62.6] vs. 14.4% [95% CI, 12.2 to 16.6]). CONCLUSIONS: H. pylori infection modified the risk of gastric cancer associated with germline pathogenic variants in homologous-recombination genes. (Funded by the Japan Agency for Medical Research and Development and others.).

来源:N Engl J Med,查看原文。版权归原作者所有。

引用

  1. Usui Y, Taniyama Y, Endo M, et al. Helicobacter pylori, Homologous-Recombination Genes, and Gastric Cancer. N Engl J Med. 2023. PMID: 36988593. doi:10.1056/NEJMoa2211807

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。